-
SFDA Deputy Commissioner Wu Zhen and Deputy Commissioner Sun Xianze meet with the delegation of Thai FDAOn the morning of September 12, 2012, SFDA Deputy Commissioner Wu Zhen and Deputy Commissioner Sun Xianze respectively met with the delegation led by Dr. Narangsant Pheerakij, Deputy Secretary-General2012/9/20
-
Lawyers seek to force J&J chief onto the stand in Risperdal caseShould Johnson & Johnson ($JNJ) CEOAlex Gorskyhave to take the stand in aRisperdalliability case? Lawyers for a Texas teen suing the company are demanding Gorsky's presence in court, saying he is2012/9/20
-
Does $1B really make a blockbuster anymore?When is a blockbuster not a blockbuster? When its sales are adjusted for inflation--or for share of the global pharma market. That $1 billion blockbuster threshold might have been a lofty goal in 192012/9/19
-
J&J to scout early-stage deals in 4 biotech hotspotsJohnson & Johnson never has made much of a mark in the sphere of early drug development. But now J&J ($JNJ) is thinking globally and acting locally, creating a plan to become a more prominent2012/9/19
-
Indian drug reps dole out gifts for scriptsIn India, drug sales reps are straightforward about what they expect from doctors--and what doctors can get in return. Just three prescriptions per day for Abbott Laboratories' ($ABT) Nupod antibiotic2012/9/18
-
Sanofi cancer drug cleared for sale, but plant remains idleSanofi Pasteur's Toronto plant can release one lot of its bladder cancer treatment for sale, Canadian regulators said. The drug, ImmuCyst, had been on hold because of problems flagged at the plant, wh2012/9/18
-
Merck decides it's smart to leave ALECAnother drug company is bailing on ALEC, the group that gets business leaders together with mostly Republican state lawmakers to write so-called model legislation, generally around business. The Ameri2012/9/17
-
SFDA issues Criteria for Writing Drug Periodic Safety Update ReportsIn order to standardize and offer guidance to the writing of drug Periodic Safety Update Reports (PSUR), improve drug manufacturers’ ability to analyze and evaluate drug safety issues, the State Food2012/9/17
-
Hisun-Pfizer workforce to more than double in sizeIn a very ambitious drive, Pfizer ($PFE) and its Chinese joint-venture partner Zhejiang Hisun Pharmaceutical intend to more than double the size of the Hisun-Pfizer workforce by the end of the year.2012/9/14
-
J&J picks Bayer AG exec to solve its consumer product messJohnson & Johnson ($JNJ) has turned to an outsider to take over its troubled consumer products division and its attendant manufacturing mess. The company today announced Sandra Peterson, who ha2012/9/14